Medicare News Blog

Drugs for prostate and breast cancer will still be covered by Medicare, despite their high costs and recent debate about the effectiveness of one.

A reader responds to a recent op-ed about AARP and its place in the emerging debate about future entitlements.

An invitation to continue the dialogue about how to improve AARP,

The Obama administration is deploying a team to pose as patients, call doctors’ offices and see how difficult it is to get care.

The drugs, mainly for men with late-stage prostate cancer, can extend lives for additional months, but some cost more than $90,000 for a course of treatment.

A reader responds to a recent front page article about the overuse of powerful CT scans.

AARP needs to get its groove back and narrow a policy agenda that has become too broad, too busy and too ambitious.

Republican candidates are short on facts when it comes to criticizing the Democrats’ plan or explaining their own.

A reader responds to a recent article about the generational conflict over political and budgetary issues.

Similarities between Democratic and Republican ideas on reforming the system are obvious, even if politicians disagree on how to get there.

Hundreds of hospitals across the country needlessly exposed patients to radiation by scanning their chests twice on the same day, records indicate.

Patients were exposed to added radiation when their chests were scanned twice on the same day, records indicate.

Joseph Lieberman and readers respond to a Paul Krugman column about the costs of Medicare compared to private insurance.

It should cover more people, not fewer.

Readers respond to a David Brooks column about Medicare and the health care system.